The use of a rapid ELISPOT assay to analyze peptide-specific immune responses in carcinoma patients to peptide vs. recombinant poxvirus vaccines.

Source:http://linkedlifedata.com/resource/pubmed/id/11129322

Download in:

View as

General Info

PMID
11129322